Zusammenfassung
Entzugssymptome sind häufig verantwortlich für den raschen Rückfall in den regelmäßigen Tabakkonsum. Sie sind als Folgen des Nikotindefizits anzusehen, verschwinden nach Gabe von Nikotin, können aber auch durch andere psychotrop wirksame Substanzen unterdrückt werden. Einzelne Arbeiten zeigen sogar, daß auch sensorische Stimulanzien, z.B. eine nikotinfreie oder mit Capsaicin angereicherte Zigarette geeignet ist, Entzugsphänomene wirksam zu unterdrücken (Behm u. Rose 1994). Inwieweit diese Befunde im Rahmen einer Raucherentwöhnung sinnvoll eingesetzt werden könnten bleibt offen — die nikotinfreie, aber schadstoffhaltige Zigarette als Entwöhnungsmittel wäre nur dann sinnvoll, wenn sich dadurch eine wirksamere Löschung des Rauchverhaltens ergäbe als mit Hilfe der anderen Entwöhnungstherapeutika.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Balfour DJK (1994) Neural mechanisms underlying nicotine dependence. Addiction 89: 1419–1423
Behm FM, Rose JE (1994) Reducing craving for cigarettes while decreasing smoke intake using capsaicin-enhanced low tar cigarettes. Experimental and Clinical Psychopharmacology 2:143–153
Berlin I, Said S, Spreux-Varoquaux O, Launay J, Olivares R, Millet V, Lecrubier Y, Puech AJ (1995a) A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Pharmacol Ther 58:444–452
Bowen DJ, Spring B, Fox E (1991) Tryptophan and high-carbohydrate diets as adjuncts to smoking cessation therapy. J Behav Med 14:97–110
Buchkremer G, Bents H, Horstmann M, Opitz K, Tolle R (1989) Combination of behavioral smoking cessation with transdermal nicotine substitution. Addict Behav 14:229–238
Cinciripini PM, Tsoh JY, Friedman K, Wetter D, Cinciripini LG, Skaar KL (1998) A placebo controlled evaluation of venlafaxine for smoking cessation: preliminary findings [Abstract A18]. In: Society for Research on Nicotine and Tobacco Annual Meeting, Mar 27-29; New Orleans
Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Meyer WJ 3rd, van Vunakis H (1995) A placebocontrolled evaluation of the effects of buspirone on smoking cessation: Differences between high-and low-anxiety smokers. J Clin Psychopharmacol 15:182–191
Dalack GW, Glassman AH, Rivelli S, Covey L, Stetner F (1995) Mood, major depression, and fluoxetin response in cigarette smokers. Am J Psychiatry 152:398–403
Edwards NB, Murphy JK, Downs AD, Ackerman BJ, Rosenthal TL (1989) Doxepin as an adjunct to smoking cessation: A double-blind pilot study. Am J Psychiatry 146:373–376
Fiore MC, Smith SS, Jorenby DE, Baker TB (1994) The effectiveness of the nicotine patch for smoking cessation. JAMA 271:1940–1947
Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli SK, Fleiss J, Cooper TB (1993) Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 54:670–679
Gourlay SG, Forbes A, Marriner T, Kutin J, McNeil J (1994) A placebo-controlled study of three clonidine doses for smoking cessation. Clin Pharmacol Ther 55:64–69
Hughes JR, Stead LF, Lancaster T (2000) Anxiolytics and antidepressants for smoking cessation (Cochrane Review). In: Cochrane Library, Issue 1, Update Software, Oxford
Hughes JR (1994) Non-nicotine pharmacotherapies for smoking cessation. J Drug Dev 6:197–203
Hurt RD, Sachs PL, Glover ED et al. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337:1195–1202
Jorenby DE, Leischow SJ, Nides MA et al. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340:685–689
Lancaster T, Stead LF (2000) Mecamlyamine (a nicotine antagonist) for smoking cessation. (Cochrane Review). In: The Cochrane Library, Issue 1, Update Software, Oxford
Leischow SJ, Sachs DPL, Bostrom AG, Hansen MD (1992) Effects of differing nicotine-replacement doses on weight gain after smoking cessation. Arch Fam Med 1:233–237
Morrow R, Nepps P, Mcintosh M (1993) Silver acetate mouth spray as an aid in smoking cessation: Results of a double-blind trial. J Am Board Fam Pract 6:353–357
Murphy JK, Edwards NB, Downs AD, Ackerman BJ, Rosenthal TL (1990) Effects of doxepin on withdrawal symptoms in smoking cessation. Am J Psychiatry 147:1353–1357
Nunn-Thompson CL, Simon PA (1989) Pharmacotherapy for smoking cessation. Clin-Pharm 8:710–720
Rose JE, Westmann EC, Behm FM (1996) Nicotine/Mecamylamine combination treatment for smoking cessation. Drug Dev Res 38:243–256
Schwartz JL (1969) A critical review and evaluation of smoking control methods. Public Health Reports 84:483–506
Silagy CA, Mant DC, Fowler GH, Lancaster T (2000) Nicotine replacement therapy for smoking cessation. (Cochrane Review). In: The Cochrane Library, Issue 1, Update Software, Oxford
Silagy CA, Mant DC, Fowler GH, Lodge M (1994) Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343:139–142
Stapleton JA, Russell MAH, Feyerabend C, Wiseman SM, Gustavsson G, Sawe U, Wiseman D (1995) Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction 90:31–42
Stead LF, Hughes JR (2000) Lobeline for smoking cessation. (Cochrane Review). In: The Cochrane Library, Issue 1, Update Software, Oxford
Sutherland G, Stapleton JA, Russell MAH, Feyerabend C (1995) Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology 120:418–425
Sutherland G, Stapleton JA, Russell MAH, Jarvis MJ, Hajek P, Belcher M, Feyerabend C (1992) Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet 340:324–329
Wallstrom M, Nilsson F, Hirsch JM (1997) A double-blind placebo controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation [abstract 2822]. European Respiratory Society Meeting, Sept 20-24, Berlin
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Batra, A. (2001). Medikamentöse Unterstützung. In: Poehlke, T., Flenker, I., Reker, M., Reker, T., Kremer, G., Batra, A. (eds) Alkohol — Tabak — Medikamente. Suchtmedizinische Versorgung, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59535-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-59535-6_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-67289-0
Online ISBN: 978-3-642-59535-6
eBook Packages: Springer Book Archive